ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeted inhibition of PTPN22 is a novel approach to alleviate osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice

Li, Shunyi; Luo, Zichao; Su, Shuwen; Wen, Liming; Xian, Gaopeng; Zhao, Jing; Xu, Xingbo; Xu, Dingli*; Zeng, Qingchun*南方医科大学
BMC Medicine2023-7-13DOI: 10.1186/s12916-023-02888-6
1被引10阅读
引用收藏
分享

摘要

Background Calcific aortic valve disease (CAVD) is the most prevalent valvular disease and has high morbidity and mortality. CAVD is characterized by complex pathophysiological processes, including inflammation-induced osteoblastic differentiation in aortic valve interstitial cells (AVICs). Novel anti-CAVD agents are urgently needed. Protein tyrosine phosphatase nonreceptor type 22 (PTPN22), an intracellular nonreceptor-like protein tyrosine phosphatase, is involved in several chronic inflammatory diseases, including rheumatoid arthritis and diabetes. However, it is unclear whether PTPN22 is involved in the pathogenesis of CAVD. @@@ Methods We obtained the aortic valve tissue from human and cultured AVICs from aortic valve. We established CAVD mice model by wire injury. Transcriptome sequencing, western bolt, qPCR, and immunofluorescence were performed to elucidate the molecular mechanisms. @@@ Results Here, we determined that PTPN22 expression was upregulated in calcific aortic valve tissue, AVICs treated with osteogenic medium, and a mouse model of CAVD. In vitro, overexpression of PTPN22 induced osteogenic responses, whereas siRNA-mediated PTPN22 knockdown abolished osteogenic responses and mitochondrial stress in the presence of osteogenic medium. In vivo, PTPN22 ablation ameliorated aortic valve lesions in a wire injury-induced CAVD mouse model, validating the pathogenic role of PTPN22 in CAVD. Additionally, we discovered a novel compound, 13-hydroxypiericidin A 10-O-alpha-D-glucose (1 -> 6)-beta-D-glucoside (S18), in a marine-derived Streptomyces strain that bound to PTPN22 with high affinity and acted as a novel inhibitor. Incubation with S18 suppressed osteogenic responses and mitochondrial stress in human AVICs induced by osteogenic medium. In mice with aortic valve injury, S18 administration markedly alleviated aortic valve lesions. @@@ Conclusion PTPN22 plays an essential role in the progression of CAVD, and inhibition of PTPN22 with S18 is a novel option for the further development of potent anti-CAVD drugs.

学科与关键词

关键词
Calcific aortic valve diseasePTPN22Natural productOsteogenic responsesMitochondrial stress
相关
加载中…
  • RETRACTED: Marine-Derived Piericidin Diglycoside S18 Alleviates Inflammatory Responses in the Aortic Valve via Interaction with Interleukin 37 (Retracted Article)
    Li, Shunyi; She, Jianglian; Zeng, Jingxin; Xie, Kaiji; Luo, Zichao; Su, Shuwen; Chen, Jun; Xian, Gaopeng; Cheng, Zhendong; Zhao, Jing; Li, Shaoping; Xu, Xingbo; Xu, Dingli*; Tang, Lan*; Zhou, Xuefeng*; Zeng, Qingchun*Oxidative Medicine and Cellular Longevity, 2022, 2022: 6776050.被引 1
  • 4-Octyl itaconate suppresses the osteogenic response in aortic valvular interstitial cells via the Nrf2 pathway and alleviates aortic stenosis in mice with direct wire injury
    Peng, Xin; Su, Shuwen; Zeng, Jingxin; Xie, Kaiji; Yang, Xi; Xian, Gaopeng; Xiao, Zezhou; Zhu, Peng; Zheng, Shaoyi*; Xu, Dingli*; Zeng, Qingchun*Free Radical Biology and Medicine, 2022, 188: 404-418.被引 9
  • Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression
    Xie, Kaiji; Zeng, Jingxin; Wen, Liming; Peng, Xin; Lin, Zhibin; Xian, Gaopeng; Guo, Yuyang; Yang, Xi; Li, Peixin; Xu, Dingli*; Zeng, Qingchun*Atherosclerosis, 2023, 364: 1-9.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Medicine
发表日期
2023-07-13
卷期
第 21 卷, 第 1 期
页码
252
DOI
10.1186/s12916-023-02888-6
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82070403, 82270374]; Science and Technology Program of Guangdong Province [2021A0505030031]; Guangzhou Science and Technology Plan Project [2023B01J1011, 2023B03J1243]; Youth Science and Technology Innovation Talent Program of Guangdong TeZhi plan [2019TQ05Y136]

作者

  • L

    Li, Shunyi (第一作者)

    southern med univ

  • L

    Luo, Zichao

    southern med univ

查看全部 9 位作者收起作者
  • S

    Su, Shuwen

    southern med univ

  • W

    Wen, Liming

    southern med univ

  • X

    Xian, Gaopeng

    southern med univ

  • Z

    Zhao, Jing

  • X

    Xu, Xingbo

  • X

    Xu, Dingli (通讯)

    southern med univ

  • Z

    Zeng, Qingchun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417